Study:ST001212
Metabolites in human pathway:Sphingolipid Metabolism detected in this study are shown in green

Metabolite listed in study ST001212HMDB pathwayKEGG pathway
3-ketosphinganine SMP0000034 Reference  | Human
3-O-Sulfogalactosylceramide (d18:1/24:0) SMP0000034 Reference  | Human
Adenosine 3',5'-diphosphate SMP0000034 Reference  | Human
Adenosine triphosphate SMP0000034 Reference  | Human
ADP SMP0000034 Reference  | Human
alpha-D-Galactose SMP0000034 Reference  | Human
Cer SMP0000034 Reference  | Human
CerP SMP0000034 Reference  | Human
D-Glucose SMP0000034 Reference  | Human
Dihydroceramide SMP0000034 Reference  | Human
Galabiosylceramide (d18:1/22:0) SMP0000034 Reference  | Human
Galactosylceramide (d18:1/16:0) SMP0000034 Reference  | Human
Galactosylglycerol SMP0000034 Reference  | Human
GalCer SMP0000034 Reference  | Human
GlcCer SMP0000034 Reference  | Human
HexCer SMP0000034 Reference  | Human
LacCer SMP0000034 Reference  | Human
L-Serine SMP0000034 Reference  | Human
M4 SMP0000034 Reference  | Human
NADP+ SMP0000034 Reference  | Human
NADPH SMP0000034 Reference  | Human
O-Phosphoethanolamine SMP0000034 Reference  | Human
Palmitaldehyde SMP0000034 Reference  | Human
Palmityl-CoA SMP0000034 Reference  | Human
PC(15:0/18:2(9Z,12Z)) SMP0000034 Reference  | Human
Phosphoadenosine phosphosulfate SMP0000034 Reference  | Human
Pyridoxal 5'-phosphate SMP0000034 Reference  | Human
SM SMP0000034 Reference  | Human
Sphinganine SMP0000034 Reference  | Human
Sphinganine-phosphate SMP0000034 Reference  | Human
Sphingosine SMP0000034 Reference  | Human
Sphingosine-1-phosphate SMP0000034 Reference  | Human
Uridine 5'-diphosphate SMP0000034 Reference  | Human
Uridine diphosphate glucose SMP0000034 Reference  | Human
  logo